<code id='99A0385184'></code><style id='99A0385184'></style>
    • <acronym id='99A0385184'></acronym>
      <center id='99A0385184'><center id='99A0385184'><tfoot id='99A0385184'></tfoot></center><abbr id='99A0385184'><dir id='99A0385184'><tfoot id='99A0385184'></tfoot><noframes id='99A0385184'>

    • <optgroup id='99A0385184'><strike id='99A0385184'><sup id='99A0385184'></sup></strike><code id='99A0385184'></code></optgroup>
        1. <b id='99A0385184'><label id='99A0385184'><select id='99A0385184'><dt id='99A0385184'><span id='99A0385184'></span></dt></select></label></b><u id='99A0385184'></u>
          <i id='99A0385184'><strike id='99A0385184'><tt id='99A0385184'><pre id='99A0385184'></pre></tt></strike></i>

          Home / entertainment / leisure time

          leisure time


          leisure time

          author:fashion    Page View:2939
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In